Skip to main content

Black Diamond Therapeutics, Inc.

BDTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001701541

No open-market purchases or sales by Black Diamond Therapeutics, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $64.9M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Black Diamond Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
87
−8 vs. Q4 2021
Shares held
22.9M
−305.7K (−1.3%) vs. Q4 2021
Total value
$63.5M
−$60.2M (−48.7%) vs. Q4 2021
New holders
11
23 more added
Sold out
19
26 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 87 institutions
Q1 2021: 113 institutionsQ2 2021: 102 institutionsQ3 2021: 101 institutionsQ4 2021: 95 institutionsQ1 2022: 87 institutionsQ2 2022: 74 institutionsQ3 2022: 69 institutionsQ4 2022: 59 institutionsQ1 2023: 50 institutionsQ2 2023: 74 institutionsQ3 2023: 73 institutionsQ4 2023: 76 institutionsQ1 2024: 88 institutionsQ2 2024: 90 institutionsQ3 2024: 96 institutionsQ4 2024: 88 institutionsQ1 2025: 85 institutionsQ2 2025: 94 institutionsQ3 2025: 91 institutionsQ4 2025: 104 institutionsQ1 2026: 104 institutionsQ2 2026: 96 institutions
Value heldQ1 2022: $63.5M
Q1 2021: $705.5MQ2 2021: $309.6MQ3 2021: $206.3MQ4 2021: $123.7MQ1 2022: $63.5MQ2 2022: $52.9MQ3 2022: $36.3MQ4 2022: $37.9MQ1 2023: $40.6MQ2 2023: $209.2MQ3 2023: $106.8MQ4 2023: $107.1MQ1 2024: $199.9MQ2 2024: $217.9MQ3 2024: $211.9MQ4 2024: $102.5MQ1 2025: $63.0MQ2 2025: $95.8MQ3 2025: $147.0MQ4 2025: $92.0MQ1 2026: $82.0MQ2 2026: $64.9M
Institutions holding BDTX and their total value by quarter
QuarterHoldersValue
Q2 202696$64.9M
Q1 2026104$82.0M
Q4 2025104$92.0M
Q3 202591$147.0M
Q2 202594$95.8M
Q1 202585$63.0M
Q4 202488$102.5M
Q3 202496$211.9M
Q2 202490$217.9M
Q1 202488$199.9M
Q4 202376$107.1M
Q3 202373$106.8M
Q2 202374$209.2M
Q1 202350$40.6M
Q4 202259$37.9M
Q3 202269$36.3M
Q2 202274$52.9M
Q1 202287$63.5M
Q4 202195$123.7M
Q3 2021101$206.3M
Q2 2021102$309.6M
Q1 2021113$705.5M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Black Diamond Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding BDTX in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
ProShare Advisors LLC0$00.00%−10,082−100.0%Sold out
Walleye Trading LLC0$00.00%−10,000−100.0%Sold out
Quantbot Technologies LP0$00.00%−6,500−100.0%Sold out
Koshinski Asset Management, Inc.0$00.00%−400−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−120−100.0%Sold out
Capital Advisors, Ltd. LLC0$00.00%−41−100.0%Sold out